Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2400133	Atrasentan片	atrasentan	Tablet	Chemical Drugs(1)	Supplementary Application	2024-08-01		Chinook Therapeutics Inc;Abbvie Ireland Nl BV			view
JXHB2300170	Atrasentan片	atrasentan	Tablet	Chemical Drugs(1)	Supplementary Application	2023-11-08		Chinook Therapeutics Inc;Abbvie Ireland Nl BV			view
JXHB2200156	Atrasentan片	atrasentan	Tablet	Chemical Drugs(1)	Supplementary Application	2022-10-10		Chinook Therapeutics Inc;Abbvie Ireland Nl BV			view
JXHL2100096	Atrasentan片	atrasentan	Tablet	Chemical Drugs(1)	Import Drug Application	2021-03-20	艾昆纬医药科技（上海）有限公司	Aikunwei Medical Technology (Shanghai) Co Ltd;Chinook Therapeutics Inc	In Review	2021-03-19	view